Hexabromocyclododecane (HBCD) and polybrominated diphenyl ethers (PBDEs) are additive flame retardants used in a wide range of consumer products. Both compounds have been detected in free-living avian species, but toxicological and molecular end points of exposure are limited. An in vitro approach was used to compare concentration-dependent effects of HBCD and the commercial penta-brominated diphenyl ether mixture DE-71 on cytotoxicity and mRNA expression in cultured hepatocytes derived from embryonic chickens. Neither HBCD-a, HBCD-technical mixture (TM), nor DE-71 effected hepatocyte viability at the highest concentrations assessed (30-100mM). Real-time RT-PCR assays were developed to quantify changes in mRNA abundance of genes associated with chicken xenobiotic-sensing orphan nuclear receptor activation, the thyroid hormone (TH) pathway, and lipid regulation. Exposure to ‡ 1mM HBCD-a and HBCD-TM resulted in significant upregulation of cytochrome P450 (CYP) 2H1 (fourfold to sevenfold) and CYP3A37 (5-to 30-fold) at 24 and 36 h. In contrast, 30mM DE-71 caused a twofold increase of CYP2H1 only. UGT1A9 expression was only upregulated by HBCD-a to a maximum of fourfold at ‡ 1mM. Transthyretin, thyroid hormone-responsive spot 14-a, and liver fatty acid-binding protein were all significantly downregulated (up to sevenfold) for cells exposed to ‡ 1mM HBCD-a and HBCD-TM. DE-71 also downregulated these three target genes twofold to fivefold at concentrations ‡ 3mM. Taken together, our results indicate that xenobiotic-metabolizing enzymes and genes associated with the TH pathway and lipid regulation are vulnerable to HBCD and DE-71 administration in cultured avian hepatocytes and might be useful molecular markers of exposure.
Brominated flame retardants (BFRs) are used in a wide range of commercial products to inhibit or suppress the combustion process. Hexabromocyclododecane (HBCD) is a commonly used BFR found in expanded and extruded polystyrene for thermal insulation foams and in the backcoating of textiles (BSEF, 2007; de Wit, 2002) . The global annual demand for HBCD is approximately 17,000 metric tons, ranking it third in global flame retardant production (Hale et al., 2006) . HBCD is currently undergoing a screening assessment under the Canadian Environmental Protection Act to determine its potential risk to the Canadian environment, and the European Union has classified HBCD as a priority substance (second priority list). Polybrominated diphenyl ethers (PBDEs) are used in products such as electrical equipment, furniture, plastics, and building materials, and the global market demand was approximately 70,000 metric tonnes in 2001 (BSEF, 2003) .
Monitoring efforts worldwide indicate that avian species are subject to HBCD and PBDE bioaccumulation. Herring gull (Larus argentatus) eggs from the Great Lakes contained 2.1-20 ng/g and 320-1200 ng/g wet weight HBCD and PBDE, respectively (Gauthier et al., 2007) . Peregrine falcon (Falco peregrinus) eggs in Sweden had mean concentrations ranging from 220 to 520 ng/g lipid weight (lw) HBCD and up to 18,000 ng/g lw PBDEs (Lindberg et al., 2004) . Interestingly, monitoring data reveal that the HBCD-a diastereomer is the most abundant in biological samples even though the HBCD technical formulation is composed predominantly of the c-diastereomer (Covaci et al., 2006; Gauthier et al., 2007) . To date, very few studies have assessed the toxicological, biochemical, or molecular consequences of HBCD exposure, and none have done so in an avian species. There are a limited number of studies that have assessed the effects of PBDEs in avian species (Crump et al., 2008; Fernie et al., 2005a; 2005b; Murvoll et al., 2005) .
Mammalian phase I and II enzymes (e.g., cytochrome P450 [CYP] 2B1, CYP3A1, uridine 5#-diphospho-glucuronosyltransferase [UGT] 1A1) have been identified as targets of HBCD and PBDE exposure; however, assessments of the avian orthologs CYP2H1, CYP3A37, and UGT1A9 have not been done. The CYPs are involved with oxidative metabolism of small, lipophilic phenobarbital-type inducers while UGT is the major phase II enzyme involved with thyroxine (T 4 ) conjugation (Germer et al., 2006; Handschin et al., 2000; Mackenzie et al., 2003) . HBCD induced CYP2B1 and CYP3A1/3A3 mRNA in rat microsomes following 28 days of treatment by gavage (Germer et al., 2006) . Canton et al. (2008) detected alterations of genes associated with phase I and II pathways, lipid metabolism, and cholesterol biosynthesis (e.g., CYP3A3, UGT, fatty acid-binding protein) in rats exposed to HBCD. The commercial penta-BDE mixture, DE-71, upregulated CYP2B and CYP3A mRNA in rat liver samples following oral administration (Sanders et al., 2005) . Such impacts on drug-metabolizing enzymes via the constitutive androstane receptor (CAR)/pregnane X receptor (PXR) signaling pathway could affect the homeostasis of endogenous substrates including thyroid hormones (THs). In fact, several studies have identified the thyroidogenic potential of HBCD and PBDEs.
Hyperthyroidal effects were observed in the T-screen assay as, even in the absence of 3,3#,5#-triiodo-L-thyronine (T 3 ), HBCD-a induced growth of the rat pituitary tumor GH 3 cell line at 1lM . In the presence of T 3 , HBCDtechnical mixture (TM), a, b, c, and various BDE congeners all had agonistic activity. The T 3 -potentiating effects of HBCD were also confirmed ex vivo in an amphibian tail tip regression assay (Schriks et al., 2006) . Thyroid hormone receptor (TR)-mediated gene expression was enhanced in HeLa cells stably expressing human TR-a1 following treatment with HBCD (3, 5, 12.5lM) in the presence of T 3 (Yamada-Okabe et al., 2005) . HBCD and various BDE congeners and commercial mixtures have been shown to deplete plasma T 4 levels in rodents and avian species (Chengelis, 2001; Fernie et al., 2005b; Fowles et al., 1994; van der Ven et al., 2006; Zhou et al., 2002) , and hydroxylated metabolites of PBDEs bound to transthyretin (TTR) in a human in vitro T 4 -TTR competitive binding assay (Meerts et al., 2000) . Disruption of TH homeostasis by HBCD or PBDEs in avian species could be critical because THs are involved in several key aspects of avian physiology including growth, development of the central nervous system, cell differentiation, and reproduction (McNabb, 2000) .
In the present study, we exposed chicken embryonic hepatocytes (CEHs) to HBCD-a and -TM and used real-time RT-PCR assays to test the hypothesis that the exposure would alter the expression of genes associated with the chicken xenobiotic-sensing orphan nuclear receptor (CXR), the TH pathway, and lipid regulation. CXR is closely related to the two mammalian xenobiotic-activated receptors, CAR/PXR, and is linked to CYP regulation (Handschin et al., 2000) . In addition, we exposed CEH to a commercial penta-BDE formulation, DE-71, to compare gene expression responses between two major classes of BFRs. This is the only study, to our knowledge, which addresses possible molecular mechanisms of action of HBCD in an avian species, and we demonstrate that several gene targets (e.g., CYP2H1, CYP3A37, UGT1A9, TTR, thyroid hormone-responsive spot 14-a [THRSP14-a], and liver fatty acid-binding protein [L-FABP] (Hamilton and Hamburger, 1951) . All procedures were conducted according to protocols approved by the Canadian Council on Animal Care Committee at the National Wildlife Research Centre.
Hepatocyte culture preparation and dosing. Cultured CEH were prepared from day 19 embryos by collagenase digestion and filtration of pooled liver samples (n ¼ 50) as described previously (Head et al., 2006; Kennedy et al., 1993) . Cell pellets were weighed and suspended in 20 ml of medium 199 (Sigma-Aldrich) per gram of pellet. Samples were plated in 48-well plates by adding 25 ll of the cell suspension to 500 ll of medium. Hepatocyte cultures were incubated at 37°C with 5% CO 2 for 24 h prior to dosing. After incubation for 24 h, solutions of HBCD-a, HBCD-TM, DE-71, and T 3 in DMSO (3.6 ll/well; nominal concentration range 0.001-30lM, 0.01-300lM, or 0.03-30nM for HBCD, DE-71, and T 3 , respectively) were added to the 48-well plates. Cells were incubated for 24 (HBCD, DE-71, T 3 ) or 36 h (HBCD only), the medium was removed, and plates were either immediately frozen and stored at À 80°C for subsequent RNA isolation or assessed for cell viability.
Cell viability determination. Cell viability was estimated using the Calcein-acetoxymethylester (AM) assay according to the manufacturer's instructions (Molecular Probes, Eugene, OR). Viability of HBCD-and DE-71-treated cells (three wells per treatment) was compared to untreated and vehicle (DMSO) controls, and cells killed with ethanol. After 45 min incubation in 200 ll Calcein-AM solution (3 ll of Calcein-AM/10 ml 13 phosphatebuffered saline/1mM ethylenediaminetetraacetic acid), plates were read in a Cytofluor 2350 fluorescence instrument (Millipore, Nepean, ON; excitation filter 485 nm; emission filter 530 nm). A one-way ANOVA was used to determine significant differences between treatment groups and the untreated control using SigmaStat v2.03 (SPSS, Point Richmond, CA).
RNA isolation and cDNA synthesis. Total RNA was obtained from CEH using TRIzol reagent as described by the manufacturer (Invitrogen, Burlington, ON). TRIzol (100 ll) was added to all 48 wells and pooled based on treatment as follows: three to four replicate pools per treatment comprised of four wells for each pool. Total RNA was treated with DNA free (Ambion, Austin, TX) and quantified by UV spectrophotometry. Total RNA (500 ng) from each of the three to four replicate pools per treatment was annealed with 150 ng random primers (Invitrogen), and cDNA was generated using Superscript II as described by the manufacturer (Invitrogen). An identical reaction without the RT was performed to verify the absence of genomic DNA (no-RT control).
Real-time RT-PCR. Primer pairs and Taqman fluorogenic probes were designed using Beacon Designer (Premier BioSoft, Palo Alto, CA) for the following gene targets: b-actin, CXR, CYP2H1, CYP3A37, UGT1A9, TR-a, TTR, deiodinase (DI) 1, 2, and 3, myelin basic protein (MBP), THRSP14-a, and L-FABP. All assays were run on the Stratagene Mx3000P or Mx3005P (Stratagene, La Jolla, CA) using Brilliant QPCR Core Reagent kits (Stratagene). Each 25-ll reaction contained primers and probes (for concentrations, see Table 1 ), 13 core PCR buffer, 5mM MgCl 2 , 0.8mM deoxynucleoside triphosphate mix, 1.25 U SureStart Taq polymerase, 8% glycerol, 75nM ROX reference dye, and 5 ll diluted cDNA. The thermocycle program included an enzyme activation step at 95°C (10 min) and 40 cycles of 95°C (30 s) and 60°C (1 min). Two triplex assays were optimized: CYP2H1 and DI3 with b-actin and CYP3A37 and DI2 with b-actin. The remaining gene targets were run in duplex with the control gene, b-actin.
Reaction efficiencies for all multiplex assays were determined using a standard curve that was generated with a 1:2 dilution series of cDNA.
Primer concentrations were optimized to ensure that the reaction efficiencies of all the genes were similar to that of b-actin. Each assay was run once in triplicate for the three to four replicate pools per treatment group, and no-RT and no template controls were included to verify the absence of contamination.
Data analysis for real-time RT-PCR. Real-time RT-PCR data were analyzed using MxPro v3.00 software (Stratagene). Cycle threshold (Ct) data were normalized to the internal control gene, b-actin, and the fold change in target gene mRNA abundance between HBCD-, DE-71-, and T 3 -treated cells and the DMSO control was calculated using 2
ÀDDCt (Livak and Schmittgen, 2001 ). Fold change data were normally distributed and passed the equal variance test for all assays. Therefore, a one-way ANOVA followed by Bonferroni t-test for multiple comparisons versus control was performed to determine statistically significant differences in mRNA abundance between DMSO-treated cells and those treated with HBCD, DE-71, or T 3 (SigmaStat v2.03; SPSS). Changes were considered statistically significant if p < 0.05.
RESULTS
Cell viability. The cell viability assay demonstrated that HBCD-a, HBCD-TM, and DE-71 were not overtly toxic to CEH at the highest concentration tested: HBCD (30lM), DE-71 (300lM) (data not shown). Importantly, the range of HBCD and DE-71 concentrations used for RNA isolation (up to 10 and 30lM, respectively) did not show a significant difference in viability compared to the untreated control. In addition, the fluorescence values of all treatment groups were significantly greater than those of the ethanol-killed cells (data not shown).
In order to put the above range of in vitro concentrations (lM) in the context of levels reported in wild avian species (ng/g), 
it was assumed that 100% of the administered compound was associated with the hepatocytes. Based on this assumption, concentrations of 0.001-0.01lM HBCD and 0.01-0.1lM DE-71 were similar to levels detected in wild avian species (Gauthier et al. 2007; Lindberg et al. 2004) .
mRNA expression. HBCD-a, HBCD-TM, and DE-71 altered mRNA levels of several gene targets associated with CXR. CYP2H1 was significantly upregulated to a maximum of fourfold at 24 h by ! 1lM HBCD-a and HBCD-TM, while ! 0.1lM HBCD-a increased expression to a maximum of sevenfold and ! 1lM HBCD-TM to a maximum of fivefold after 36 h (Figs. 1A and B) . Additionally, DE-71 upregulated CYP2H1; however, the maximal fold induction was 2 at concentrations 103 greater than those that elicited a response in HBCD-exposed CEH ( Figure 1A) . The other phase I metabolizing enzyme assessed, CYP3A37, was induced significantly at 24 and 36 h following exposure to ! 1lM HBCD-a and HBCD-TM, but DE-71 did not significantly alter mRNA expression (Figures 2A and B) . The maximal fold induction of CYP3A37 was greater at 36 than 24 h for both HBCDs (e.g., 30-vs. 10-fold at 10lM HBCD-a). UGT1A9, a phase II metabolizing enzyme, was significantly upregulated by ! 1lM HBCD-a at 24 and 36 h, but neither of the other compounds altered its expression ( Figures 3A and B) . The receptor associated with CYP regulation, CXR, remained unchanged at all doses and time points for HBCD-a (e.g., Figure 4 ) and HBCD-TM (data not shown). DE-71, on the other hand, caused a slight downregulation of CXR at the highest concentration tested (Figure 4) . T 3 treatment, the positive control for TH-dependent gene expression, significantly increased TR-a mRNA levels at 0.3nM by approximately sixfold (Figure 5 ). TR-a returned to basal (i.e., DMSO) levels at 3 and 30nM implying a desensitization to excess agonist. TTR mRNA was downregulated by ! 2-fold by HBCD-a, HBCD-TM, and DE-71 at concentrations ! 3lM at 24 h ( Figure 6A) . However, the effect of HBCD on TTR was diminished at 36 h ( Figure 6B ). HBCD-TM caused a dose-dependent decrease of THRSP14-a at concentrations ! 1lM at 24 and 36 h, whereas HBCD-a only had a significant effect at 10lM at both time points ( Figures 7A  and B) . DE-71 decreased expression by as much as fivefold at ! 3lM ( Figure 7A ). The three DIs and MBP were not FIG. 1. The relative expression of CYP2H1 mRNA in CEH following treatment with DE-71, HBCD-TM, and HBCD-a for 24 (A) or 36 (B) h. mRNA abundance was determined by real-time RT-PCR, and fold changes were calculated based on the DMSO control. Error bars represent the SEM, and a one-way ANOVA was used to determine significant differences (n ¼ 3-4; *p < 0.05).
FIG. 2. CYP3A37 mRNA expression after 24 (A) or 36 (B)
h of exposure to DE-71, HBCD-TM, and HBCD-a. Real-time RT-PCR data were corrected by the internal control gene b-actin, and fold changes were based on the DMSO control. Statistically significant differences were determined by a one-way ANOVA (n ¼ 3-4; *p < 0.05).
responsive to any of the treatments at either time point (data not shown).
HBCD-a downregulated L-FABP mRNA to a maximum of fivefold at 24 and 36 h at ! 1lM ( Figures 8A and B ). HBCD-TM had an effect on L-FABP expression at 10lM following 24 h of exposure, whereas the response was much more pronounced (up to a sixfold decrease) at ! 1lM at 36 h ( Figures 8A and B) . L-FABP mRNA was also downregulated to a maximum of threefold by ! 3lM DE-71 ( Figure 8A ). 
DISCUSSION
This is the first study, to our knowledge, to assess the impacts of HBCD and DE-71 on toxicity and mRNA expression in cultured avian hepatocytes. HBCD and PBDEs have been detected in free-living avian species, and we demonstrate that although these compounds were not overtly toxic to CEH at the highest concentrations administered, they had a significant, yet variable, impact on the expression of genes associated with CXR activation, the TH pathway, and lipid regulation.
Expression of CXR is restricted to tissues where drug induction of CYPs predominantly occurs (e.g., liver), and it mediates xenobiotic responses through the regulation of CYP2H1 (Handschin et al., 2000) . We did not detect a significant change in CXR for HBCD-treated CEH; however, there was a slight decrease in expression following DE-71 exposure. Previous work from our laboratory demonstrated that several nuclear receptors (TR-a and -b, nicotinic acetylcholine receptor a-7, peroxisome proliferator-activated receptor-a [PPAR-a]) were ineffective molecular markers of contaminant exposure in vitro, and the CXR results appear to corroborate this (Crump et al., 2008, in press; Cwinn et al., 2008) . Several mammalian studies that evaluated the effects of BFRs on PXR/ CAR activation did not measure changes in receptor mRNA levels but, instead, genes encoding phase I and II metabolizing enzymes (Canton et al., 2008; Germer et al., 2006; Pacyniak et al., 2007; Sanders et al., 2005) . The phase I metabolizing enzyme CYP2H1 was upregulated by HBCD in CEH implying CXR activation despite the lack of effect on the receptor itself. CYP3A37 was also upregulated by HBCD, and the maximal induction was greater than that observed for CYP2H1. Germer et al. (2006) reported a significant induction of both CYP2B and CYP3A mRNA in rats exposed to HBCD-TM where CYP3A elicited a more pronounced response. The authors suggested that CYP3A induction was among the most sensitive end points of HBCD exposure in higher animals reported to date, and our data support this claim. In addition, CYP3A3 was the most responsive gene in a microarray study where exposure to HBCD induced expression by as much as 12-fold in male rats (Canton et al., 2008) . For both enzymes, the maximal fold induction in CEH was greater following 36 h of exposure, and thus, this time point will be used in our future screening assays with other compounds.
DE-71 upregulated CYP2H1 approximately twofold; however, upregulation was only observed at a concentration 10 times higher than that which elicited a response in HBCDexposed cells. CYP3A37 expression was unaffected by DE-71. CYP2B was more responsive than CYP3A in rats exposed to DE-71 with maximal mRNA inductions of 45- (Sanders et al., 2005) and 110-fold observed (Pacyniak et al., 2007) . The magnitude of change for both enzymes was much lower in CEH, but CYP2H1 was more responsive than CYP3A37 which corroborates the mammalian studies. The variable sensitivity of these molecular end points to HBCD and DE-71 is particularly interesting given the possibility of using HBCD as a replacement alternative for PBDEs (Canton et al., 2008; Covaci et al., 2006; Sellstrom et al., 1998) .
In addition to regulating phase I metabolizing enzymes, PXR/CAR regulates the expression of phase II enzymes, including UGT1A1 (Mackenzie et al., 2003) . To our knowledge, there are no studies that demonstrate an effect of HBCD on the avian ortholog, UGT1A9; however, Canton et al. (2008) observed an induction of UGT1A1 mRNA in rat hepatic tissue following oral administration of HBCD. In avian hepatocytes, UGT1A9 was upregulated in a dose-dependent manner by HBCD-a, but HBCD-TM had no effect. Typically, HBCD commercial mixtures comprised between 75-90% HBCD-c, 10-13% HBCD-a, and 1-12% HBCD-b; however, in all monitoring studies done to date, HBCD-a is the most abundant diastereomer in biological samples (Covaci et al., 2006; Gauthier et al., 2007) . Thus, the diastereomer-specific results for UGT1A9 expression in CEH are relevant for developing a molecular marker for avian wildlife. DE-71, like HBCD-TM, did not alter UGT1A9 expression in this study, but Zhou et al. (2001) observed an increase in UGT activity in weanling rats exposed to 10 mg/kg DE-71.
UGT1A1 is the major T 4 -conjugating UGT and can alter circulating T 4 levels by making it more excretable by the kidneys (Germer et al., 2006; Mackenzie et al., 2003) . Wong et al. (2005) reported that PXR induction of UGTs together with the biliary conjugate export pump Mrp2 can lead to a massive depletion in blood T 4 levels. T 4 levels were decreased in rats exposed for 90 days to HBCD-TM, and the predominant diastereomer in adipose tissue was HBCD-a (Chengelis, 2001) . Similarly, van der Ven et al. (2006) reported a significant depletion of T 4 in female rats exposed to HBCD-TM and a dose-dependent increase of T 4 -UGT activity. The increase in UGT1A9 mRNA in this study expands the current understanding of HBCD effects and represents a likely mechanism for HBCD-associated T 4 depletion. Interestingly, the diastereomer that predominates in biological samples was the only one that altered UGT1A9 in CEH. The lack of response to DE-71 indicates that PBDE-associated T 4 depletion in rodents and birds (Fernie et al., 2005b; Fowles et al., 1994; Zhou et al., 2002) may not be associated with glucuronidation.
To further explore the impacts of HBCD and DE-71 on the TH pathway, several TH-regulated mRNAs were assessed. The cultured cells were TH responsive as TR-a was significantly upregulated following treatment with T 3 . TTR expression was downregulated ! 2-fold by HBCD and DE-71 at 24 h. TTR is synthesized in the liver, maintains extrathyroidal stores, and regulates the supply of hormone to target tissues (McNabb, 2007) . A decrease in transport protein could lead to an inefficiency of maintaining T 4 levels, an end point observed in HBCD and PBDE studies (see above discussion). A decrease in total serum T 4 levels was also observed in a TTR-null mutant mouse line (Episkopou et al., 1993) highlighting the potential importance of this transport protein as a target for contaminant-induced depletions in circulating hormone levels. The magnitude and direction of change was the same as that observed in other in vitro assays with avian neuronal cells treated with DE-71 (Crump et al. 2008, in press ) revealing a consistent response among different avian species and tissue types. However, this molecular end point was time dependent as significant depletion was not observed at 36 h for HBCD. Unlike the phase I and II enzymes, the ideal time point to assess TTR expression was 24 h in cultured cells.
We also observed a significant reduction in THRSP14-a, a transcription factor involved in regulating adipogenic enzymes, following exposure to HBCD and DE-71. THRSP14-a is thought to play a role in TH stimulation of lipogenesis (LaFave et al., 2006) and its downregulation in CEH varied depending on the compound assessed. Unlike the elevated responsiveness of UGT1A9 to the more biologically relevant HBCD-a diastereomer, THRSP14-a levels decreased in a dosedependent manner following exposure to HBCD-TM while HBCD-a only affected expression at the highest dose tested (10lM). THRSP14-a was selected based on its TH responsiveness, and it had not been previously identified as a target of BFR action. Exposure to T 3 upregulated THRSP14-a mRNA by ninefold in mice (Feng et al., 2000) and TH deprivation/ hypothyroidism decreased levels (Weiss et al., 1998; Zavacki et al., 2005) . The downregulation of THRSP14-a mRNA in CEH following treatment with HBCD and DE-71 is in line with a depleted TH status, an end point confirmed in previous mammalian and avian studies. These data not only identify lipid regulation as a potential target but also provide further indication that TH homeostasis is negatively affected by exposure to these BFRs and extend our understanding of underlying molecular mechanisms of action.
One proposed mechanism behind reduced plasma T 4 concentrations in American kestrels exposed to PBDEs was increased conversion of T 4 to T 3 through hepatic monodeiodinase enzymes (Fernie et al., 2005b) . If this were the case, it would be predicted that mRNA levels of DIs involved in outer ring 5#-deiodination would be upregulated (e.g., DI2 and to a lesser extent DI1). In the present study, we did not detect changes in any of the DIs implying that the more plausible mechanism behind some of the observed T 4 depletions in BFR studies is glucuronidation. MBP is activated by T 3 via a TH response element in the promoter region (Pilar et al., 1999) and was included in this study as a potential target of BFR action. Although MBP is TH responsive, like the DIs, expression levels were unaltered following HBCD and DE-71 exposure. MBP is expressed to a greater extent in brain tissue, and future BFR EFFECTS ON CHICKEN mRNA EXPRESSION studies could include this end point when assessing affects on neuronal cells. However, for this study, the DIs and MBP were determined to not be useful molecular markers of exposure.
Finally, L-FABP expression followed a similar trend to that observed for TTR and THRSP14-a, downregulation following exposure to HBCD and DE-71. L-FABP, like THRSP14-a, responded to HBCD treatment at both 24 and 36 h with a slightly greater fold change observed at the latter time point. L-FABP belongs to a superfamily of lipid-binding proteins and is important for the metabolism and intracellular transportation of lipids (Wang et al., 2006) . L-FABP is regulated by PPAR-a in mammals as mRNA levels parallel those of PPAR-a, and PPAR-a ligands increase L-FABP gene expression (Iwen et al., 2001; Skrtic et al., 2005) . However, in CEH, fenofibrate, a known PPAR-a agonist, did not alter the mRNA levels of L-FABP, indicating that its regulation was independent of PPAR-a activation (Cwinn et al., 2008) . L-FABP mRNA levels were induced following ip administration of T 3 to hypothyroid Wistar rats (Iwen et al., 2001) , and perhaps, a depleted TH status resulting from BFR exposure could lead to a downregulation of L-FABP as observed in the present study. Regardless, the consistent effect of the two BFRs on two genes associated with lipid regulation is intriguing and extends our understanding of the potential pathways that are targeted in avian species. These data also corroborate a study which found that HBCD exposure resulted in downregulation of several genes associated with lipid metabolism/regulation, including fatty acid-binding protein, in rat hepatic tissue (Canton et al., 2008) .
In conclusion, we identified several mRNAs that were responsive to two classes of BFRs in an avian species using an in vitro screening tool. Phase I and II metabolism, TH transport, and lipid regulation and transportation emerged as candidate mechanisms of action of HBCD and DE-71. The magnitude of mRNA expression response varied depending on the BFR and time point assessed. In general, HBCD elicited a greater response than DE-71, and this finding has important implications in terms of using HBCD as a replacement alternative for PBDEs. HBCD-a typically demonstrated a greater response than the TM which has significant relevance to the observed predominance of HBCD-a in biological samples. The genes that were most responsive could represent effective molecular biomarkers in future studies with additional BFRs and other avian species. 
